Charles River Laboratories (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2001 | 12-2000 | 09-2000 | 06-2000 | 03-2000 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 72,399 | 33,129 | 28,000 | 18,990 | 18,450 |
| Receivables | 78,295 | 45,949 | 48,290 | 50,930 | 53,020 |
| Inventories | 34,287 | 34,510 | 31,540 | 32,190 | 32,460 |
| Income taxes - deferred | 2,055 | 2,055 | N/A | N/A | N/A |
| Other current assets | 8,166 | 4,094 | 6,440 | 6,220 | 7,840 |
| TOTAL | $195,202 | $119,737 | $114,270 | $108,330 | $111,770 |
| Non-Current Assets | |||||
| PPE Net | 139,694 | 117,001 | N/A | N/A | N/A |
| Investments And Advances | 2,514 | 2,442 | 2,370 | 2,160 | 2,080 |
| Intangibles | 91,529 | 41,893 | 0 | 0 | 0 |
| Other Non-Current Assets | 126,446 | 132,472 | 163,910 | 170,640 | 167,900 |
| TOTAL | $360,183 | $293,808 | $166,280 | $172,800 | $169,980 |
| Total Assets | $555,385 | $413,545 | $395,260 | $398,900 | $400,940 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 16,153 | 231 | 130 | 6,440 | 7,440 |
| Accounts payable and accrued liabilities | 10,814 | 10,767 | 7,960 | 8,690 | 9,770 |
| Accrued Expenses | 56,437 | 44,635 | 42,110 | 42,340 | 54,270 |
| Other current liabilities | N/A | N/A | 5,730 | 5,800 | 6,860 |
| TOTAL | $99,300 | $64,320 | $60,550 | $67,070 | $84,790 |
| Non-Current Liabilities | |||||
| Long Term Debt | 228,302 | 201,957 | 202,220 | 392,740 | 311,390 |
| Deferred Revenues | 11,760 | 5,223 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 15,848 | 16,745 | 25,870 | 40,150 | 17,840 |
| TOTAL | $256,944 | $229,361 | $235,460 | $440,470 | $337,280 |
| Total Liabilities | $356,244 | $293,681 | $296,020 | $507,560 | $422,100 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 40,128 | N/A | N/A | N/A | N/A |
| Common Shares | 401 | 359 | 1 | 190 | 1 |
| Retained earnings | -311,624 | -318,575 | -122,310 | -298,740 | -129,030 |
| Other shareholders' equity | -19,595 | -13,324 | -15,681 | -12,510 | -11,591 |
| TOTAL | $199,141 | $119,864 | $99,230 | $-108,660 | $-21,150 |
| Total Liabilities And Equity | $555,385 | $413,545 | $395,250 | $398,900 | $400,950 |